Coya Therapeutics, Inc. Common Stock (COYA) — Capital Reinvestment Ratio

Latest as of March 2024: 0.01x

Coya Therapeutics, Inc. Common Stock (COYA) has a Capital Reinvestment Ratio of 0.01x as of March 2024, meaning it reinvests 0% of its operating cash flow ($2.15 Million) in capital expenditures ($25.00K). See debt-free asset ratio of Coya Therapeutics, Inc. Common Stock to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$2.15 Million
USD

Capital Expenditures

$25.00K
USD

Data as of

Mar 2024
Most recent filing

Annual Capital Reinvestment Ratio for Coya Therapeutics, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Coya Therapeutics, Inc. Common Stock from None to None. For live market cap and broader valuation context, see COYA market cap.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow